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Abstract 
The diuretic effects of the water extract of Musanga cecropioides was investigated to see the mechanism of its 
reported blood lowering effect. Sprague dawley rats were divided into four groups and giving water, 
1.33mg/100ml, 5.3mg/100ml and furosemide (0.6mg/100ml). The water intake and the urine volume were 
measured and their cation content was determined by flame photometry. Musanga cecropioides extract 
(1.33mg/100ml) increases urinary output, sodium excretion significantly (p< 0.001) compared to control. There 
was no significant difference in these parameters between Musanga cecropioides and furosemide. This suggests 
a diuretic effect. Chemical analysis of the plant shows a flavonoid, tannin, alkaloid, anthraquinone and reducing 
sugar which alone or in combination may account for this diuretic effect and thus the antihypertensive 
mechanism. 
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1.0 INTRODUCTION 
Hypertension, for several decades has been globally recognised as the most prevalent cardiovascular disease. It is 
reported to be the next to malaria as most serious health problem in developing tropical countries (Gilford, 1975, 
Agunwa, 1998, Ajagbonna, 2000). 
Presently there are several classes of agents in current use in the control of hypertension. They are 
classified based on their primary site of action. These includes (i) diuretics like furosemide which lower blood 
pressure by increasing urinary water and sodium excretion (Aguiyi and Obi, 1998). (ii) sympatholytic drug such 
as guanethidine, which lower blood pressure by reducing the peripheral resistance and cardiac output (Falase and 
Balako, 1979, Oduntola, 1989). (iii) Angiotensin converting enzyme inhibitors such as captopil which lower 
blood pressure by blunting the normal aldosterone response  to sodium loss, thus,the normal role of aldosterone 
to oppose diuretic induced natriuresis is diminished. 
The uses of these conventional antihypertensive agents have been associated with arrays of side effects 
apart from the high cost some of these drugs. 
If therefore becomes imperative to search for a novel drug with better cost effectiveness and lesser side 
effects. 
In some part of the world and indeed Nigeria, medicinal plants and plant products are employed in the 
management of several diseases especially hypertension (Ajagbonna and Adegunloye, 1998, Ajagbonna and 
Onyeyili, 2002, Ajagbonna et al, 2002) one of these plant is Musanga cecropioides. 
Musanga cecropioides is a rapidly growing plant belonging to the cecropiaceae family ubiquitous to 
the tropical rain forests particularly of West Africa. It i known as the ‘umbrella tree’ (from its shapeor cork word 
English parasolier (for its close resemblance to a parasol). 
Traditionally, preparation from various part of the plant such as the leaves, latex, stem bark and roots 
are used as remedies for various illness especially hypertension, trypanosomiasis, leprosy, chest infection and 
rheumatism (Bouquest, 1969). 
More specifically, water that exude from the cut stem of the plants is reported to have a diuretic effect 
and thereby lowering blood pressure. While several workers have demonstrated the scientific basis for some of 
the reported traditional use of the plant very little or no work has been done to validate the diuretic claim of this 
plant. Thus, this study was design to investigate the mechanism involved in the reported blood lowering effect of   
the water extract of Musanga cecropioides with the aimof demonstrating and reevaluate the diuretic effect of 
graded doses of the aqueous extract of the plant stem bark in the normotensive rats. 
 
 
2.0 METHODOLOGY 
2.1 COLLECTION OF WATER EXTRACT OF MUSANGA CECROPIOIDES 
The liquid extract of Musanga cecropioides  was collected  from the deciduous forest of Ijebu Igbo in Ijecu 
North Local government of Ogun State, Nigeria. This was obtained by a cut of the stem of the plant with a 
cutlass. The exuded liquid from the cut stem is then collected into a container. The collected water extract used 
in this study is colourless and odourless. 
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2.2 EXPERIMENTAL ANIMALS 
Healthy Sprague Dawley rats of both sexes weighing between 170-230gms were obtained from Veterinary 
animal unitof Amadu Bello University Zaria. These animals were allowed to acclimatise to laboratory condition 
for  two weeks. Water and feed (vitafeed® ltd Nigeria) were provided adlibitum throughout the course of the 
experiment. 
 
2.3 EXPERIMENTAL GROUPING 
The rats were randomly divided into 4 groups (1-4) of 5 rats as follows 
Group 1 control group and were given only distilled water 
Group 2 Rats were given 5.3mg/100ml of Musanga cecropioides water 
Group 3 Rats were given 1.33mg/100ml of Musanga cecropioides 
Group 4 Rats were given standard drug (Furosemide at a dose rate of 0.6mg/kg) 
 
2.4 PREPARATION FOR FUROSEMIDE SOLUTION 
Furosemide tablets (Fidson Nig Ltd) were ground into powdered and dissolved in distilled water. Drug dose was 
determined based on the volume of solution consumed per average weight of rats. 
 
2.5 DETERMINATION OF DAILY FLUID INTAKE 
Usually a known volume of water, Musanga cecropioides water extract or furosemide solution was placed in the 
appropriate cage in the morning. The following morning, 24 hours after, the volume of the fluid remaining was 
measured. Fluid intake was determined by subtractingthe volume of the fluid left from the initial volume of the 
fluid placed in the cage. 
 
2.6 METABOLIC CAGE AND URINE COLLECTION 
Daily urine volume from the rats were determined using metabolic cage. Usually two rats were randomly picked 
from each group and placed in the metabolic cage. The rats were left in the cages overnight and urine was 
collected, measured and stored in a freezer until required for analysis. The process was repeated for three weeks. 
At the end of the experiment, the cation (Na+ and k+) contents of the urine samples were determined by flame 
photometry. 
 
2.7 ACUTE TOXICITY EFFECT OF MUSANGA CECROPIOIDES WATER 
A group of 5 rats were administered with 5.3mg/100ml of Musange cecropioides water . Each of the animals was 
placed in a metabolic cageand observed for 48hours and for any short-term behaviour signs or death. They were 
later observed for 12 days for a long-term possible lethal outcome. 
 
2.8 STATISTICAL ANALYSIS 
Results are presented as mean ± standard error of mean (SEM). Statistical analysis was done using oneway 
analysis of variance (ANOVA). P<0.05 and P< 0.001 was regarded as statistically significant. 
 
3.0 RESULTS 
3.1 PYTOCHEMICAL STUDIES 
Phytochemical analysis from this study shows that the extract contains alkaloids, tannins, cardiac glycosides, 
flavonoids, anthraquinones,phlobatannins, anthocyaaaaaanosides, saponins, cyanogenic glycosides and reducing 
sugar 
 
3.2 ACUTE TOXICITY STUDY 
Administration of the water of Musanga cecropiodes  for short term of 48 hours and long term of 12 days did not 
produce death nor any observable lethat behavioural signs. 
 
3.3 EFFECT OF MUSANGA CECROPIODES ON FLUID INTAKE 
The daily fluid intake in the four groups. There was no significant difference in daily fluid intake of all the 
groups of rats at the beginning of the experiment (week 0). 
The fluid intake was however significant lower (p<0.001) in the group that was given  5.3mg/100ml Musanga 
cecropiodes compared to the other three groupds. The fluid intake in the test group (group with 1.3mg/100ml 
and that of furosemide) was also significantly lower (p<0.001) than the control group. 
 
3.4 EFFECT OF MUSANGA CECROPIODES ON URINARY SODIUM 
Represent the daily sodium excretion of control rats and the test groups with the Musanga cecropiodes  water 
and those that consume furosemide solution. These was no significant difference in urinary sodium excretion 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.5, No.13, 2015 
 
49 
between all the groups at the beginning of the experiment (week 0) 
The urinary sodium excretion was however signifantly higher (p<0.05) in all the test groups compare to control 
for the three week period. The highest sodium excretion was however observed in the group that took 
1.33mg/100ml Musanga cecropiodes  
 
3.5 EFFECT OF MUSANGA CECROPIODES ON POTASSIUM EXCRETION 
Shows the daily k+ excretion in all the four groups 
At the beginning of the experiment, there was no significant difference between the groups. However, by the 
second and third week, the  k+ excretion of Musanga cecropiodes (1.33mg/100ml) rats and that of furosemide 
was significantly higher (p<0.001) than the control rats. 
 
3.6 EFFECT OF MUSANGA CECROPIODES AND FUROSEMIDE ON URINE OUTPUT 
Represent the daily urinary output of the control rats and the test group with Musanga cecropiodes and 
furosemide solution. 
At the beginning (week 0) there was no significant difference (p<0.05) in the urine output among the 
groups, however, by week 1 through week 3, urine output of the rats given (1.33mg/100ml) Musanga 
cecropiodes  was significantly higher (p<0.001) than control rats and rats consuming 5.3mg/100ml Musanga 
cecropiodes.  The significant increase is comparable to that shown in rats taking furosemide. 
Table 3.1:   PHYTOCHEMICAL RESULT FOR Musanga cecropiodes WATER EXTRACT 
S/NO TEST RESULTS 
A 
1 
2 
3 
ALKALOIDS 
Dragen Doff’s Reagent 
Mayer’s Reagent 
Wagner’s Reagent 
 
+ 
+ 
+ 
 
B 
1 
2 
TANNINS 
Feric Chloride Reagent 
Bromine Water 
 
+ 
+ 
 
C 
1 
2 
3 
4 
5 
CARDIAC- GLYCOSIDE 
Legal Test 
Keddle Test 
Liebermans’s Test 
Salkowski Test 
Keller- Kiliani Test 
 
+ 
+ 
+ 
+ 
+ 
 
D 
1 
2 
3 
FLAVONOID’S TEST 
Ferric Chloride Test 
Lead Acetate Test 
Sodium Hydroxide Test 
 
+ 
+ 
+ 
 
E 
1 
ANTHRAQUINONES 
Borntragers Test 
 
+ 
 
F PHLOBATANNINS TEST + 
 
G ANTHOCYANOSIDES TEST 
 
- 
H 
1 
2 
3 
SAPONINS TEST 
Benedict’s Test 
Frothing Test 
Emulsion Test 
 
+ 
+ 
+ 
 
I CYANOGENIC GLYCOSIDES 
 
- 
 
J 
1 
2 
3 
4 
REDUCING SUGAR COMPOUND 
Fehling Test 
Barfoed Test 
Resorcinol Test 
Phloroqlucinol Test 
 
+ 
+ 
+ 
+ 
+  Represent presence of the chemical constituent in the plant 
- Represent absence of the chemical constituent in the plant 
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Table 3.2: The daily urinary volume of control rats and rats given extract (5.3mg/100ml), extract  
(1.33mg/100ml) and furosemide. 
 WEEK 0 WEEK 1 WEEK 2 WEEK 3 
Group 1 
(control) 
 
1.5 ± 0.12 1.3 ± 0.19 1.69 ± 0.19 1.5 ± 0.12 
Group 2 
(extract 
5.3mg/100ml) 
 
136.5 ± 8.56 208.0 ± 17.24** 203.33 ± 10.48* 213 ± 16.56** 
Group 3 
(extract 
1.33mg/100ml) 
 
153.0 ±4.32 321.33 ± 15.76*** 347.33 ± 45.11*** 336.33 ± 24.27*** 
Group 4 
(furosimide) 
160 ± 6.9 290.67 ±14.7*** 240.67 ± 29.45*** 289.33 ± 25*** 
n = 5, values are represented as Mean ± SEM 
**     represents values are significant at P < 0.01 
***   represents values are significant at P < 0.001. 
NS. Represents values are not significant at P > 0.05 compared with the control. 
 
 
Figure 3.0 showing the The daily urinary volume of control rats and rats given extract (5.3mg/100ml), extract  
(1.33mg/100ml) and furosemide. 
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Table 3.3: The daily urinary Na+ excretion of control rats and rats given extract (5.3MG/100ML) and 
furosemide. 
 WEEK 0 WEEK 1 WEEK 2 WEEK 3 
Group 1 
(control) 
 
148 ± 2.45 129.67 ± 1.45 143.33 ± 5.78 173.0 ± 13.0 
Group 2 
(extract ,5.3mg/100ml) 
 
136.5 ± 8.56 208.0 ± 17.24** 203.33 ± 10.48* 213 ± 16.56** 
Group 3 
(extract 1.33mg/100ml 
) 
 
153.0 ± 4.32 321.33±  15.76*** 347.33± 45.11*** 336.33± 24.27*** 
Group 4 
(furosemide) 
160 ±6.9 290.67 ± 14.7*** 240.67± 29.45*** 
 
289.33 ± 25*** 
n = 5, values are represented as Mean ± SEM 
** represents values are significant at P< 0.01 
*** represents values are significant at P< 0.001 
NS. Represents values are not significant at P> 0.05 compared with the control. 
 
 
Figure 3.1: showing The daily urinary Na+ excretion of control rats and rats given extract (5.3MG/100ML) and 
furosemide. 
Table 3.4: The daily urinary potassium excretion of control rats and rats given extract (5.3MG/100ML) extract 
and furosemide. 
 WEEK 0 WEEK 1 WEEK 2 WEEK 3 
Group 1 
(control) 
 
263.75 ± 12.34 246.67 ± 9.62 328.67 ± 42.49 309 ± 30.99 
Group 2 
(extract 
5.3mg/100ml) 
 
286.0 ± 25.46 305.67 ± 28.43 NS 402.0 ± 72.51 NS 331.67 ± 22.30 NS 
Group 3 
(extract 
1.33mg/100ml) 
 
291.27 ± 22.80 385.67 ± 11.92 NS 404.0 ± 55.85 NS 475 ± 63.06 NS 
Group 4 
Furosemide 
280.12 ± 19.81 407.0 ± 34.78 NS 403.67 ± 43.05 NS 404.33 ± 22.33 NS 
n = 5, values represents as Mean ± SEM  *represents values are significant at P <0.05 
*** represents values are significant at P< 0.001 ‘NS’ represents values are not – significant at P >0.05 
compared with control. 
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Figure 3.2 showing the daily urinary potassium excretion of control rats and rats given extract (5.3MG/100ML) 
extract and furosemide. 
 
Table 3.5: The daily fluid intake of control rats and rats given extract (5.3MG/100ML), extract 
(1.33MG/100ML) and furosemide. 
 WEEK 0 WEEK 1 WEEK 2 WEEK 3 
Group 1 
(control) 
 
79.0 ± 1.7 59.67 ±1.15 89.00 ± 2.6 89.00 ±2.08 
Group 2 
(extract 
5.3mg/100ml) 
 
83.0 ± 1.37 42.0 ± 1.16***  44.67 ± 0.88*** 46.33 ± 1.2*** 
Group 3 
(extract 
1.33mg/100ml) 
 
80.91 ± 2.32 70.0 ± 1.16*** 67.33 ±3.53*** 70.0 ± 0.58*** 
Group 4 
(furosemide) 
85.43 ± 1.23 64.0 ±1.16 71.67 ±1.20*** 69.67 ± 0.88 
n = 5, values are represented as Mean ± SEM 
***  represents values are significant at P, 0.001 compared with control. 
 
 
Figure 3.3 showing the daily fluid intake of control rats and rats given extract (5.3MG/100ML), extract 
(1.33MG/100ML) and furosemide 
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4.0 DISCUSSION  
Result from this study demonstrate that oral water extract of Musanga cecropiodes produced an increase in daily 
urine output in normotensive rats. 
In this study, two concentration 5.3mg/100ml and 1.33mg/100ml of Musanga cecropiodes were given 
to rats compared to control rats that drank water only and the rats that took furosemide, a standard diuretic drug. 
This study shows that at concentration of 1.33mg/100ml, Musanga cecropiodes  significantly increased urine 
volume of rats compared to control. The diuretic effect observed here is similar to that of furosemide, a standard 
diuretic drug known to increase urine output, thus suggesting a diuretic effect by the Musanga cecropiodes at 
this concentration.  
The dieresis was not likely to be due to increased fluid intake because fluid intake of rats on 
1.33mg/100ml Musanga cecropiodes did not differ significantly from the water intake by the control rats, neither 
was it significantly different from the fluid intake by the rats on furosemide solution. 
However, surprisingly, increasing the concentration of Musanga cecropiodes to 5.3mg/100ml did not 
result in grater diuretic effect, rather it led led to a significantly lower production of urine. This urine observation 
may be due to the fact that this group of rats, that drank 5.3mg/100ml Musanga cecropiodes drank significantly 
far less of the solution than the control rats, and rats that drank 1.33mg/100ml Musanga cecropiodes  and the rats 
on furosemide. It is possible that at this concentration (5.3mg/100ml) the solution of Musanga cecropiodes has 
become bitter causing the rats to drink it sparingly resulting in a lack of a diuretic effect. This observation is 
similar to thyat reported by some earlier workers on Hibiscus sabdariffa and Rhaptopetalum corcaeum extract, 
plants that were also earlier showed to posses diuretic property (Mojiminiyi, et al., 2000, Ajagbonna, et al., and 
Ajagbonna and Onwuchekwa, 2000) 
Substance that increase urine output are known to reduce blood pressure (Ajagbonna et al., 2003,). The 
above finding suggest that  at a concentration of 1.33mg/100ml, Musanga cecropiodes  solution may be working 
as a diuretic and this may be an additional mechanism of its blood pressure lowering effect. Already, it had been 
reported that Musanga cecropiodes extract produced a fall in systolic and diastolic blood pressure in 
normotensive rats (Adeneye et al., 2005). A therapeutically useful diuretic does not only increase sodium 
excretion (Adegunloye, 1996, Ajagbonna, et al., 2002). 
Musanga cecropiodes (1.33mg/100ml) in this study increase sodium excretion (table 3),this effect is 
similar to that observed with furosemide a standard drug that increases sodium excretion by blocking Na-K+ 
ATPase (Adegunloye, 1996). This suggest that Musanga cecropiodes may have also reduse blood pressure by 
increasing sodium excretion (natriuresis) 
Potassium excretion was higher in Musanga cecropiodes  rats and furosemide treated ratsrats 
compared to control in this study. Diuretic like the thiazides are known to enhance excretion in tubules and 
collecting ducts which are subsequently reabsorbed in exchange for excreted potassium, (Okenwa, 1997). This 
may suggested a diversity in the diuretic action on Musanga cecropiodes  which may be due to presence of one 
or more active component in water extract. 
Phytochemical analysis of Musanga cecropiodes shows it contain alkaloids, tannins, flavonoids, 
cardiac glycoside, anthraquinones and reducing sugar. These substance alone or in combination may be 
responsible for the diuretic property observed in the study. 
It can therefore be concluded that observation from this study support to a large extent the claims by 
the traditional medicine practitioner that water of Musanga cecropiodes may contain active substances that may 
be responsible for its diuretic property and therefore subsequently explain additional mechanism for the 
antihypertensive effects of this plant. 
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